Table 2 Echocardiographic features and outcomes of the study population
From: Isolated tricuspid valve surgery; long-term outcomes based on Tehran Heart Center data bank report
Characteristic | Implant Type | P Value | |
|---|---|---|---|
Repair (n = 150) | Replacement (n = 47) | ||
Post-operation | |||
Dyspnea | 24 (16.0) | 5 (10.6) | 0.365 |
Orthopnea | 0 (0.0) | 1 (2.1) | 0.239 |
Palpitation | 4 (2.7) | 2 (4.3) | 0.630 |
Acute chest pain | 2 (1.3) | 1 (2.1) | 0.561 |
NYHA functional class, mean (SD) | 1.05 (0.25) | 1.12 (0.42) | 0.373 |
Ejection fraction, mean (SD) | 51.12 (5.02) | 47.72 (5.50) | 0.005 |
TAPSE, mean (SD) | 16.80 (3.52) | 16.20 (3.77) | 0.422 |
RVD, mean (SD) | 34.80 (6.31) | 32.20 (5.33) | 0.064 |
PAP, mean (SD) | 32.00 (9.29) | 30.66 (8.06) | 0.514 |
ICU, h | 55.11 (54.08) | 158.34 (286.67) | 0.020 |
Ventilation time | 14.91 (30.25) | 89.56 (256.44) | 0.058 |
Length of stay, d | 9.34 (4.48) | 18.21 (16.39) | 0.001 |
Events | |||
Readmission | 5 (3.3) | 0 (0.0) | 0.341 |
Malfunction/valve thrombosis | 2 (1.3) | 3 (6.4) | 0.089 |
Redo surgery | 0 (0.0) | 7 (14.8) | 0.000 |
Hemorrhagic stroke | 1 (0.6) | 0 (0.0) | 1.000 |
Endocarditis | 2 (1.3) | 0 (0.0) | 1.000 |
Mortality | 5 (3.3) | 15 (32.6) | 0.000 |